SIC
AKTS

SJS Investment Consulting’s Aktis Oncology AKTS Stock Holding History

SJS Investment Consulting’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06K Buy
+33
New +$678 ﹤0.01% 2009

Other funds holding AKTS

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SJS Investment Consulting's AKTS Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Aktis Oncology (AKTS) in Q2 2026: 33 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #2009 among its holdings.

10 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • SJS Investment Consulting held 33 shares of Aktis Oncology worth $1.06K as of Q2 2026.
  • Aktis Oncology was a new SJS Investment Consulting position in Q2 2026.
  • Aktis Oncology made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2009 holding.
  • 10 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.